Vulvar vestibulitis: Treatment by botulinum toxin;Vestibulite vulvaire: Traitement par la toxine botulinique

Annales de Dermatologie et de Venereologie

Volumn 133, Issue 10, 2006, Pages 807-808

  Bennani, B ^a   Raki, S ^a   Monnier, G ^b   Pelletier, F ^a   Humbert, Ph ^a  

^a HÔPITAL SAINT JACQUES   (France)

^b UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BOTULINUM TOXIN;

ADULT; CASE REPORT; CONTRACEPTION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DYSPAREUNIA; ERYTHEMA; FEMALE; HUMAN; LETTER; SYMPTOMATOLOGY; URINARY TRACT; VULVAR VESTIBULITIS; VULVODYNIA;

EID: 33750043461     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(06)77610-4     Document Type: Article

References (9)

1. Brun JL, Grafeille N. Vestibulite et dyspareunie d'intromission. Rev Prat 1997;47:1661-6.
2. Woodruff JD, Friedrich EG. The vestibulitis. Clin Obstet Gynecol 1985;25:134-41.
3. Heller DS, Randolph P, Young A Tancer ML, Fromer D. The cutaneous-vulvar clinic revisited: a 5-year experience of the Colombia Presbyterian medical center cutaneous-vulvar service. Dermatology 1997;195:26-9.
4. Furlonge CB, Thin RN, Evans BE, McKee PH. Vulvar vestibulitis syndrome: a clinical-pathological study. Br J Obstet Gynaecology 1991;98:703-6.
5. Tympanidis P, Terenghi G, Dowd P. Increased innervation of the vulvar vestibule in patients with vulvodynia. Br J Dermatol 2003;148:1021-7.
6. Friedrich EG. Vulvar vestibulitis syndrome. J Reprod Med 1987;32:110-4.
7. Lundqvist EN, Hofer PA, Olofsson JI, Sjoberg I. Is vulvar vestibulitis an inflammatory condition? A comparison of histological findings in affected and healthy women. Acta Derm Venereol 1997;77:319-22.
8. Edwards L. New concepts in vulvodynia. Am J Obstet Gynecol 2003;189:s24-s40.
9. Gunter J, Brewer A, Tawfik O. Botulinum Toxine A for vulvodynia: a case report. J Pain 2004;5:238-240.